Cholesterol-lowering drugs — statins — may increase risk of diabetes and cognitive problems, says FDA

Some cholesterol-lowering drugs, or statins, received updated labels today from the U.S. Food and Drug Administration.

According to an FDA press release,

important safety changes to the labeling for some widely used cholesterol-lowering drugs known as statins are being announced today.

These products, when used with diet and exercise, help to lower a person’s “bad” cholesterol (low-density lipoprotein cholesterol). The products include: Lipitor (atorvastatin), Lescol (fluvastatin), Mevacor (lovastatin), Altoprev (lovastatin extended-release), Livalo (pitavastatin), Pravachol (pravastatin), Crestor (rosuvastatin), and Zocor (simvastatin). Combination products include: Advicor (lovastatin/niacin extended-release), Simcor (simvastatin/niacin extended-release), and Vytorin (simvastatin/ezetimibe). [Continue reading…]

Michael Foods Recalls Hard-Cooked Eggs Sold In 34 States Due to Listeria Threat

The FDA and Michael Foods, Inc. announced the recall of  15,000 pails of eggs in brine, sold for institutional use. The eggs were recalled due to the concern that they could cause listeria.

Listeria can cause short-term symptoms

such as hi

gh fever, severe headache, stiffness, nausea, abdominal pain and diarrhea in healthy people. But it can be a serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. [Continue reading…]